Drug comparisons
Canagliflozin vs Rosiglitazone
Compare Canagliflozin and Rosiglitazone for type 2 diabetes treatment options, including mechanisms, benefits, risks, and which drug might be better for you.
No comparison dimensions are available for this page.
Clinical context
This comparison typically arises for type 2 diabetes patients considering alternatives after metformin or weighing SGLT2 inhibitors against TZDs based on cardiovascular or renal status.
Bottom line
Canagliflozin may be preferable for those with heart or kidney disease due to proven benefits, whereas Rosiglitazone suits insulin-resistant patients, but individual factors decide the winner.
All medication comparisons